First published in 1975, the McGill Pain Questionnaire (MPQ) is an oftencited pain measure, but there have been no systematic reviews of the MPQ in cancer populations. Our objective was to evaluate the MPQ as a multidimensional measure of pain in people with cancer. A systematic search of research that used the MPQ in adults with cancer and published in English from 1975 to 2009 was conducted. Twenty-one articles retrieved through computerized searches and nine studies from manual searches met the criteria. Review of the 30 studies demonstrated that pain intensity (n ¼ 29 studies) and pain quality (n ¼ 27 studies) were measured more frequently than pain location, pattern, and behavior parameters. Measuring cancer pain using the MPQ provided insights about disease sites, magnitude of pain, and effectiveness of treatment and intervention. Additionally, the MPQ data informed speculations about pain mechanisms, emotional status, overall sensory pain experience, changes in pain over time, and alleviating and aggravating behaviors/factors. Findings supported the MPQ as an effective multidimensional measure with good stability, content, construct, and criterion validity and showed sensitivity to treatment or known-group effects. The MPQ is a valid, reliable, and sensitive multidimensional measure of cancer pain. Cancer pain is a subjective complex experience consisting of multiple dimensions, and measuring cancer pain with the MPQ may help clinicians to more fully understand whether those dimensions of cancer pain influence each other. As a result, clinicians can provide better and effective cancer pain management.
The evaluation of cancer pain remains a troubling issue because of the subjective experience of pain and the complexity of the disease (McGuire, 1995; Wilkie & Monreal, 1999) . Many investigators have used the multidimensional conceptualization of cancer pain as a framework for assessing and studying cancer pain as a subjective perception (Turk, Monarch, & Williams, 2002) . The McGill Pain Questionnaire (MPQ) is a comprehensive multidimensional measure (Ahles, Blanchard, & Ruckdeschel, 1983; McGuire, 1995; Melzack & Wall, 1965; Wilkie & Monreal, 1999 ) that quantifies neurophysiologic as well as psychologic domains of pain. The MPQ thus allows a comprehensive approach to measure cancer pain. Although the MPQ has been used in many cancer studies, few reviews have been found to date on its use in exclusively cancer populations. Therefore, the purpose of the present integrative review was to critically analyze the knowledge about the multiple dimensions of pain when measured by the MPQ in cancer populations.
Based on the Gate Control Theoretical framework, Melzack and Torgerson (1971) developed the MPQ to measure the pain experience from multiple dimensions: sensory (pain location, intensity, quality, and pattern), affective (fear, depression, and anxiety related to pain); cognitive (overall pain appraisal), and behavioral (aggravating and alleviating actions) (Ahles, Blanchard, and Ruckdeschel, 1983; Melzack, 1975; Melzack & Torgerson, 1971) . Widely used in multiple studies, the MPQ has demonstrated good reliability and validity (Melzack, 1975) and has discriminated among different pain diagnoses. Because participants take $25-30 minutes to complete the MPQ long version, it is commonly used in clinical research more than in practice (Flaherty, 1996) .
The MPQ includes five main measures (McGuire, 1984; Melzack, 1975; Wilkie, Savedra, Holzemer, Tesler, & Paul, 1990 ):
1. Pain location (sensory dimension). On a drawing of the human body with both anterior and posterior sides, participants indicate the areas of their bodies that have pain. The number of pain sites is summed as in indicator of the sensory pain dimension. 2. Pain intensity (sensory dimension). Participants rate the intensity of their current, least, and worst pain and their worst headache, stomachache, and toothache by responding to six separate questions on the strength of their pain. From a list of six words, the patient selects the one best word describing the intensity of pain: 0 ¼ none; 1 ¼ mild; 2 ¼ discomforting; 3 ¼ distressing; 4 ¼ horrible; and 5 ¼ excruciating. 3. Pain quality (sensory, affective, and cognitive dimensions). Participants respond to the question, ' 'What does your pain feel like?' ' by selecting from 78 descriptors in 20 subclasses. The descriptors are used qualitatively or they are combined quantitatively in several measures. The quantitative data are summed to form the pain rating index (PRI) which includes PRI-Total (PRI-T, score 0-78), PRI-Sensory (PRI-S, score 0-42), PRI-Affective (PRI-A, score 0-14), PRI-Evaluative (PRI-E, score 0-5), and PRIMiscellaneous (PRI-M, score 0-17) (Katz & Melzack, 1999) . In addition, the qualitative data include 78 descriptors of pain quality that describe pain characteristics in three dimensions of pain: 1) sensory qualities (word groups 1-10, 17-19) described in terms of temporal, spatial, pressure, thermal, and other properties; 2) affective qualities (word groups 11-15, 20) described in terms of tension, fear, and autonomic properties; and 3) cognitive qualities or evaluative words (word groups 16, 20) that describe the overall appraisal of the pain (Katz & Melzack, 1999) . Finally, the number of words chosen (NWC, is the sum score of the total number of descriptors that the participant chooses. Since 1975, only two literature reviews of the MPQ were found, but one review focused on the normative scores obtained with the MPQ when used in a variety of pain populations (Wilkie, Savedra, Holzemer, Tesler, and Paul, 1990) and the other review focused on cross-cultural adaptation of the MPQ (Menezes Costa Lda, Maher, McAuley, & Costa, 2009) . No published review of the empirical studies in which the English version of the MPQ was used to measure pain in cancer populations was found. From studies in which the MPQ was used to measure pain in people with cancer, the specific objective of the present study was to critically analyze: 1) the knowledge generated about the multiple dimensions of pain; and 2) the psychometric properties of the MPQ.
METHODS
A systematic search of three databases (Ovid, Medline, and Ebsco) was conducted using these key words and combinations: ''cancer pain,'' ''cancer-related pain,'' ''McGill Pain Questionnaire,'' ''pain pattern'' and ''temporal pain aspect'' (Fig. 1) . The search was limited to research studies in humans published in English from 1975 (when the MPQ was published) to 2009.
Article Selection
Initially, there were a considerable number of studies found with the key words ''cancer,'' ''cancer pain,'' and ''cancer-related pain.'' Then, the key words were combined with the term ''McGill Pain Questionnaire,'' and the search was limited to the adult population. The studies were limited to those in which the investigators used the MPQ to measure pain and published in English. Twenty-one unique articles met the inclusion criteria and were retrieved from the Ovid, Medline, and Ebsco databases. Manual searches of the reference lists of the 21 studies produced an additional nine studies. The 30 articles were read to confirm that they met the inclusion criteria. One article was identified with the minimum age < 18 years, but it was retained because most of the sample was adults.
RESULTS
An overview of each of the 30 studies is presented in Table 1 . Various study designs were used; samples were either convenience or purposive sampling; and settings included oncology centers, pain clinics, acute care, ambulatory care, surgery unit, hospice care, and home. Most studies were conducted in the United States and the rest in Canada (Epstein & Stewart, 1993; Melzack, 1975) , Australia (Heim & Oei, 1993) , Taiwan (Huang, Wilkie, Chapman, & Ting, 2003) , United Kingdom (Macdonald, Bruce, Scott, Smith, & Chambers, 2005; Twycross & Fairfield, 1982) , Austria (Peintinger, Reitsamer, Stranzl, & Ralph, 2003) , and Israel (Talmi, Waller, Bercovici, Horowitz, Pfeffer, Adunski, and Kronenberg, 1997) .
Demographic Characteristics
Across all studies, ages ranged from 15 years (Sist, Florio, Miner, Lema, & Zevon, 1998) to 92 years (Zimmerman, Story, Gaston-Johansson, & Rowles, 1996) , and the average age across the studies was 59 years. Both female and male subjects were included in 23 studies. The distribution of race/ethnicity in 11 studies was more caucasians than others. A few studies were conducted in all-caucasian samples (Beck, 1991; Samuelsson & Hedner, 1991; Zimmerman, Pozehl, Duncan, & Schmitz, 1989) . There were six studies in which the investigators reanalyzed data from the same sample (Dobratz, 2001 (Dobratz, , 2008 Wilkie & Keefe, 1991; Wilkie, Keefe, Dodd, & Copp, 1992) or had some of the same participants (Berry, Wilkie, Huang, & Blumenstein, 1999; Fischer, Villines, Kim, Epstein, & Wilkie, 2009; Wilkie, Huang, Reilly, & Cain, 2001 ).
Cancer Characteristics
Overall, the maximum time period since participants had been diagnosed with cancer was 84 months (McGuire, 1984) . The four most common cancers studied were head and neck (Epstein & Stewart, 1993; Epstein, Wilkie, Fischer, Kim, & Villines, 2009 Huang, Wilkie, Chapman, et al., 2003; Nicholson, McGuire, & Maurer, 1988; Talmi et al., 1997) , lung (Wilkie, Huang, Reilly, and Cain, 2001; Wilkie & Keefe, 1991; Wilkie, Keefe, Dodd, and Copp, 1992; Wilkie, Williams, Grevstad, & Mekwa, 1995) , breast (Macdonald, Bruce, Scott, Smith, and Chambers, 2005; Peintinger, Reitsamer, Stranzl, and Ralph, 2003; Stevens, Dibble, & Miaskowski, 1995) , and prostate (Heim & Oei, 1993) . Participants across the studies were diagnosed with stage IV (41%-75%), stage III (14%-35%), stage II (4%-36%), and stage I (7%-17%) cancer. More than 50% of the participants reported that the main source of pain was bone metastasis (Beck, 1991; Berry, Wilkie, Huang, and Blumenstein, 1999; Coward & Wilkie, 2000; Greenwald, 1991; Sist, Florio, Miner, Lema, and Zevon, 1998; Stevens et al., 1995; Wilkie et al., 1995; Zimmerman et al., 1989) . In general, the most frequent cancer treatments were radiotherapy, chemotherapy, surgery, and combinations of those treatments.
Pain Characteristics
The maximum range of time that participants had been living with cancer pain before participating in the study was >24 months (Epstein et al., 2009 ). Researchers reported pain related to cancer (Beck, 1991; Fischer et al., 2009; Heim & Oei, 1993; Wilkie & Keefe, 1991; Wilkie et al., 1995) or specified the categories of cancer pain, such as: somatic, visceral, neuropathic, and radiating pain (Burrows, Dibble, & Miaskowski, 1998; Stevens et al., 1995) , nociceptive, neuropathic; and a mix of both nociceptive and neuropathic pain (Epstein et al., 2009; Huang, Wilkie, Chapman et al., 2003; Wilkie et al., 2001; Wilkie et al., 1992) . Table 2 presents the pain measures and pain parameter findings. Researchers reported findings for all pain parameters; location (18 studies), intensity (29 studies), quality (27 studies), pattern (15 studies), and behavior (17 studies). Pain Location. The maximum number of pain sites across the studies was 16 sites (Epstein et al., 2009) . Participants (93%) reported their pain distribution was internal (Beck, 1991) , external, or both internal and external (McGuire, 1984; Wilkie et al., 1992) . Pain location was reported from the primary cancer pain site (Dobratz, 2001 (Dobratz, , 2008 Epstein & Stewart, 1993; Fischer et al., 2009; Greenwald, 1991; Peintinger et al., 2003; Talmi et al., 1997) and was consistent with the disease sites (McGuire, 1984) or the metastatic sites of the cancer (Talmi et al., 1997) . Women reported more pain locations (mean 4, SD 1.4) than men (mean 3, SD 1.7), but their cancers were not the same (Coward & Wilkie, 2000) . The number of pain sites was associated with coping self-statements (r ¼ 0.34) (Wilkie & Keefe, 1991) . When comparing 15 participants with breast and colon cancer, participants with breast cancer reported a total of 60 distinct anatomic pain sites, whereas participants with colon cancer reported 40 pain sites (Twycross & Fairfield, 1982) . Pain Intensity. Most participants reported that current pain intensity was discomforting (Graham, Bond, Gerkovich, & Cook, 1980; Heim & Oei, 1993; Nicholson et al., 1988) to distressing (McGuire, 1984) . Mean intensity scores of pain caused by somatic etiologies was higher than pain caused by nerve and visceral etiologies (Burrows et al., 1998) . Researchers combined the MPQ with other measures, such as the visual analog scale (VAS), numerically-anchored VAS, numerical pain intensity scale, and graphic rating scales. When comparing cancer pain and other common pains (headache, toothache, and stomachache) and primary cancer site, participants with cancer pain had a lower mean score of worst pain intensity than worst ever toothache, but higher than worst ever headache and stomachache (Berry et al., 1999) . Participants with head and neck cancer reported a higher mean score of pain intensity (mean 1.5, SD 1.0) than those with lung (mean 1.3, SD 1.0) and prostate (mean 1.0, SD 0.9) cancer (Fischer et al., 2009) . For the worst pain intensity, participants with lung cancer reported higher mean scores (mean 3.4, SD 1.2) than those with head and neck (mean 3.0, SD 1.3) and prostate (mean 2.7, SD 1.3) cancer (Fischer et al., 2009) . Participants with head and neck cancer had more intense pain (distressing) during and after the course of radiotherapy (Epstein & Stewart, 1993) whereas participants with nasopharyngeal carcinoma had the severest pain in the second week (Epstein et al., 2009 ) and the fifth week during the course of radiotherapy (Huang, Wilkie, Chapman et al., 2003) . Participants with axillary lymph node dissection surgery reported higher pain intensity than those with sentinel lymph node biopsy (Peintinger et al., 2003) . After the operation, participants with breast cancer surgery still reported pain intensity from 1 day to 1 week (Stevens et al., 1995) and up to 9 years (Macdonald et al., 2005) . Two intervention studies (Beck, 1991; Zimmerman et al., 1989) showed that music affects pain intensity but not mood. Pain Quality. Participants with neuropathic pain reported higher mean scores on the PRI-S, PRI-M, PRI-T, and NWC than those with visceral and somatic pain, whereas participants with visceral pain reported higher mean scores on the PRI-A and PRI-E than those with neuropathic and somatic pain (Burrows et al., 1998) . Participants with mixed both nociceptive/neuropathic pain had higher mean scores on all PRI and NWC subscales than those with neuropathic pain and with nociceptive pain (Wilkie et al., 2001) . Participants with lung cancer had higher mean scores for the PRI and NWC than those with head and neck and prostate cancer (Fischer et al., 2009) . Men reported higher mean scores on all PRI and NWC subscales than women (Coward & Wilkie, 2000) . With visual comparison of the normative mean scores (NMS) in cancer (Wilkie et al., 1990) , the mean scores of all pain quality of those studies were higher than the NMS in four studies (Graham et al., 1980; McGuire, 1984; Melzack, 1975; Zimmerman et al., 1996) , but lower than the NMS in 11 studies (Berry et al., 1999; Burrows et al., 1998; Coward & Wilkie, 2000; Dobratz, 2001; Epstein et al., 2009; Fischer et al., 2009; Nicholson et al., 1988; Wilkie et al., 2001; Wilkie & Keefe, 1991; Wilkie et al., 1992; Zimmerman et al., 1989) .
Pain Parameters Measured
Investigators in ten studies reported that the pain quality affective scores were primarily used to study psychologic factors (depression, trait anxiety, and state anxiety) associated with pain (Ahles et al., 1983; Beck, 1991; Burrows et al., 1998; Fischer et al., 2009; Greenwald, 1991; Kremer, Atkinson, & Ignelzi, 1982; Sist et al., 1998; Wilkie & Keefe, 1991; Zimmerman et al., 1989; Zimmerman et al., 1996) . Participants with depression reported higher PRI-A scores and selected more affective descriptors than those without depression (Sist et al., 1998) . At a statistically significant level (p < .05), participants with lung cancer had higher mean scores on all PRI and NWC subscales than those with head and neck and prostate cancer (Fischer et al., 2009) . Similarly, all PRI scores of pain quality among participants with lung cancer were correlated (r ¼ 0.43-0.50) with the catastrophizing subscale of the pain Coping Strategies Questionnaire (Wilkie & Keefe, 1991) . In two studies (Beck, 1991; Zimmerman et al., 1989) , investigators reported that using music therapy decreased all PRI scores. Pain quality descriptors predicted pain types (Wilkie et al., 2001) , and catastrophizing was significantly associated with the evaluative pain quality of the MPQ (r ¼ 0.44) (Wilkie & Keefe, 1991) . Pain Pattern. The frequency of pain patterns was reported in 12 studies (Beck, 1991; Coward & Wilkie, 2000; Epstein & Stewart, 1993; Epstein et al., 2009; Fischer et al., 2009; Huang, Wilkie, Chapman et al., 2003; McGuire, 1984; Nicholson et al., 1988; Twycross & Fairfield, 1982; Wilkie et al., 2001; Wilkie & Keefe, 1991; Wilkie et al., 1992) . Investigators of only one study reported the pain pattern mean score, which could range from 0 to 6: as 2.9 AE 1.4 (median PRI mean scores were PRI-S (10.9 AE 7.4), PRI-A (2.1 AE 2.3), PRI-E (1.9 AE 1.5), PRI-M (2.7 AE 2.9), PRI-T (17.6 AE 11.8), NWC (7.5 AE 4.4). PRI-S, -M, -T, and NWC mean score in pts w/neuropathic pain were higher than pts w/visceral and somatic pain; the PRI-A, -E in pts w/visceral pain were higher than neuropathic and somatic pain. pts w/somatic pain had higher mean score of mood disturbance than visceral, neuropathic, and pain free PRI mean score of lung CA were PRI-S (10.4 AE 7.8), PRI-A (1.5 AE 2.1), PRI-E (1.6 AE 1.7), PRI-M (2.7 AE 2.9), PRI-T (16.1 AE 12.4). PRI mean score of HNC were PRI-S (8.7 AE 6.9), PRI-A (0.9 AE 1.6), PRI-E (1.2 AE 1.4), PRI-M (1.9 AE 2.7), PRI-T (12.6 AE 10.5) PRI mean score of prostate CA were PRI-S (7.7 AE 6.6), PRI-A (0.8 AE 1.7), PRI-E (1.2 AE 1.4), PRI-M (2.2 AE 3.2), PRI-T (11.8 AE 11) Pain quality was significantly greater in lung compared to HNC and prostate Pain quality ratings were partially predicted by having lung Depression levels were significantly greater for pt w/lung Catastrophizing was correlated w/high level w/depression and anxiety The ability to control pain were reinterpreting (HNC), praying/hoping (LC). NWC, PRI-T, pain intensity was predicted by coping strategies. NWC was predicted by gender Pain pattern (range 0-6) mean score was 2.9 AE 1.4 (median ¼ 3. Pain intensity (VAS) was correlated w/ castrophizing (r ¼ 0.46).
Mean scores: PRI-S (13.7 AE 7.4), PRI-A (2.5 AE 2.5), PRI-E (2.2 AE 1.7), PRI-M (3.9 AE 3.6), PRI-T (22.2 AE 12.9), NWC (8.9 AE 4.6) Pts w/lung (42%) did not tell about their pain to others, 40% indicated that they told others Preferences for not telling others were associated w/more frequent pain coping attempts for all CSQ subscales -Pain intensity (VAS) was correlated w/ability to control pain (r ¼ À0.45), and ability to decrease pain (r ¼ À0.56)
State anxiety demonstrated positive correlation w/castrophizing coping strategies (r ¼ 0.48), and negative correlation w/ability to control (r ¼ À0.50), and decrease pain (r ¼ À0.50) Most pain quality scores showed moderatestrong correlation (r ¼ 0.40-0.44) w/total coping score Wilkie et al. 1992 MPQ VAS Pts (67%) had internal pain site and 33% had both internal and external Most pts reported multiple pain sites (1-9 sites, mean 4, SD 1.9)
Pain intensity mean score (VAS) ¼ 25.5, SD 28.3
Mean scores: PRI-S (13.7 AE 7.4), PRI-A (2.5 AE 2.5), PRI-E (2.2 AE 1.7), PRI-M (3.9 AE 3.6), PRI-T (22.2 AE 12.9), NWC (8.9 AE 4.6) 3.0) (Fischer et al., 2009) . Participants with an intermittent pain pattern had mild to moderate pain intensity, whereas participants with a continuous pain pattern had severe to excruciating pain intensity. In addition, participants with an intermittent pain pattern reported fewer pain locations, lower quality, and fewer behaviors than those with a continuous pain pattern (Stevens et al., 1995) . In three studies, a larger proportion of participants had continuous pain than other patterns (McGuire, 1984; Wilkie et al., 2001; Wilkie et al., 1992) . Intermittent pain patterns were more reported by participants with head and neck (Nicholson et al., 1988), lung, and prostate (Fischer et al., 2009 ) cancer than other patterns. Participants selected more than one word to describe their pain patterns (Coward & Wilkie, 2000; McGuire, 1984; Nicholson et al., 1988) . Pain Behavior. Taking analgesic drugs was the most common behavior to alleviate pain (Beck, 1991; McGuire, 1984; Melzack, 1975; Nicholson et al., 1988; Stevens et al., 1995; Wilkie et al., 1992) , and movement was the most common behavior to aggravate pain (Ahles et al., 1983; McGuire, 1984; Nicholson et al., 1988; Stevens et al., 1995; Twycross & Fairfield, 1982; Wilkie et al., 1992) . Participants with continuous pain patterns reported that movement, fatigue, and emotion increased pain intensity whereas only movement increased pain intensity for participants with intermittent pain pattern (Stevens et al., 1995) . Medication intake was significantly correlated with all three components of pain (sensory, affective, and evaluative). Activity level was negatively correlated with affective and evaluative scores (Ahles et al., 1983) . In one study, investigators developed a video observational method in participants with lung cancer and found that 42 behaviors controlled pain (Wilkie et al., 1992) and that these behaviors differed from the pain-related behaviors reported as MPQ pain alleviation behaviors. For example, pain control behaviors included repositioning, passive and active pressure manipulation, guarding, bracing, and immobilization.
Validity and Reliability
Investigators reported either the validity (16 studies) or reliability (four studies) of the MPQ. In only one study (Twycross & Fairfield, 1982) investigators did not report either validity and reliability.
Validity. Four groups of investigators reported the construct validity (Kremer et al., 1982; McGuire, 1984; Melzack, 1975; Sist et al., 1998) . Five studies supported the strength of the content validity by a theoretical framework (Wilkie et al., 1992) , conceptual framework (Beck, 1991) , and theoretical definition (Coward & Wilkie, 2000; Dobratz, 2008; Macdonald et al., 2005) . Five investigative groups reported criterion validity (Ahles et al., 1983; Beck, 1991; Fischer et al., 2009; Sist et al., 1998; Wilkie et al., 2001) . Reliability. The reliability of the MPQ was reported as a test-retest reliability of 0.70 (Melzack, 1975) , and the effects of four repeated measures in a cancer population supported the reliability (66%-80.4%) of the MPQ (Graham et al., 1980) . Test-retest reliability was presented over an interval of 3 days for pain intensity (r ¼ 0.57) and all PRI scores of pain quality (r ¼ 0.31-0.82) (Wilkie & Keefe, 1991) . In two studies, investigators reported the interrater reliability for agreement of coders: agreement for the cause of pain (85%-92%) (Huang, Wilkie, Chapman et al., 2003; Wilkie et al., 2001 ) and pain mechanism (90%) (Huang, Wilkie, Chapman et al., 2003) . Sensitivity. Investigators reported the sensitivity to the effect of the intervention (Beck, 1991; Zimmerman et al., 1989) and found that music therapy decreased pain intensity. Six studies reported the sensitivity to the effect of the treatment (Epstein & Stewart, 1993; Epstein et al., 2009; Huang, Wilkie, Chapman et al., 2003; Macdonald et al., 2005; Peintinger et al., 2003; Talmi et al., 1997) .
Usability Issue
Two sets of investigators reported issues related to participants' ability to use the MPQ (McGuire, 1984; Talmi et al., 1997) . McGuire (1984) reported that hospitalized participants with cancer took $24 minutes to complete the paper version of the MPQ (range 12-45 minutes). Also participants (number not reported) with cancer felt that it was difficult to describe their pain appropriately by selecting from 78 pain adjective descriptors. Talmi et al. (1997) found that seven out of 62 participants were not able to complete the MPQ. In neither study did investigators report reasons why the participants had difficulty or were not able to complete the MPQ. Recently, the MPQ has been developed as a computerized version (Painreportit) that participants (n ¼ 213) completed within an average 16 (SD 6.7) minutes (Wilkie et al., 2003) .
DISCUSSION
These integrative review findings provide a portrait of the MPQ as a multidimensional measure of pain in people with cancer. Across the 30 studies were participants with cancer who typically had three pain sites and discomforting pain intensity. Of 78 pain descriptors, participants with cancer selected descriptors representative of all three dimensions (sensory, affective, and cognitive). Participants' reports of pain patterns were inconsistent, depending on differences in cancer type and treatments. Taking analgesic drugs was the main method to alleviate participants' pain, whereas participants' movement that affected the disease area was the key cause of aggravating their pain. The sensory pain dimension was the most frequently reported pain dimension in all of the studies. Pain location based on an anatomic distinction was related to the primary source (cancer diagnosis) and secondary sources of pain, including metastases, surgical location, complications of chemotherapy and/or radiotherapy, and referred pain. Mostly, participants with cancer indicated more than one pain site that was usually an internal site, which means that the pain occurred from deep somatic, visceral, or neuronal tissue damage rather than an external pain caused by superficial tissue damage. Pain location of the MPQ was validated in participants with cancer (McGuire, 1984) . Therefore, monitoring body outline may be useful in clinical practice, because it provides an empirical documentation of pain location for the medical record and, with repeated measures, reflects the progression of the spatial distribution of the pain.
Participants with cancer overall evaluate cancer pain as moderate pain, compared with reports of intense pain when subjects had indicators of nervous tissue damage (neuropathic pain) (Wilkie et al., 2001) , during radiotherapy treatment, or after the course of radiotherapy (Epstein & Stewart, 1993; Huang, Wilkie, Chapman, et al., 2003) . And participants' pain pattern varied when they were receiving radiotherapy (Epstein & Stewart, 1993; Huang, Wilkie, Chapman, et al., 2003) . However, because pain is a dynamic sensation that changes over time, frequent pain measurement provides clinicians with accurate pain information (Jensen & McFarland, 1993) to determine and provide the pain medications for pain control.
It was noted that the emotional status of participants was associated with sensory pain when investigators combined the MPQ and other instruments (VAS and other intensity scales, Coping Strategies Questionnaire, State-Trait Anxiety Inventory, and Center for Epidemiologic Studies Depression Scale). Participants with cancer who were depressed reported higher pain intensity (Kremer et al., 1982) than those who were not depressed (Sist et al., 1998) . Interestingly, it was noted in the present review that coping strategies were associated with pain intensity and quality as measured by the MPQ (Wilkie & Keefe, 1991) , but only the catastrophizing subscale score from the Coping Strategies Questionnaire was correlated with other psychologic factors, including depression level and state and trait anxieties (Fischer et al., 2009 ). Focusing on decreasing catastrophizing could be an important factor to decrease participants' pain, which is a hypothesis that deserves additional research. The combination of the MPQ with other tools provides additional validity and important clinical information about participants with cancer and pain who also are affected by physiologic and psychologic conditions. Pain-related behavior is associated with pain location in a weight-bearing structure, such as shoulders, arms, and legs, and is exacerbated by movement (Ahles & Martin, 1992) . For example, participants with head and neck cancer aggravated their pain when eating, drinking, and swallowing (Huang, Wilkie, Chapman et al., 2003; Nicholson et al., 1988) . Taking pain medication was the most common means of alleviating participants' pain. Therefore, providing pain medication before a patient's activity can help him or her to maintain pain relief. Observation of pain behaviors by videotaping (Wilkie et al., 1992) may be an effective method for clinicians to record participants' pain control behaviors, because it provides additional information not obtained with the MPQ.
These results support the MPQ as a valid, reliable, and sensitive multidimensional measure to measure pain in people with cancer. Because cancer pain is a dynamic phenomenon, the reliability of pain measures is typically less strong in measuring pain over time than when measures are in close proximity. As a result, the validity of pain measures becomes more crucial (Jensen, Karoly, O'Riordan, Bland, & Burns, 1989) . Up to now, pain measurement has tended to recognize sensitivity to treatment effect and the assessment of treatment outcomes (Caraceni, 2001 ). The present results also support that the MPQ detects changes induced by the treatments and interventions and changes associated with pain outcome predictors. Interestingly, the review findings documented that pain was less in the more recent studies (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) than in studies from the 1980s and early 1990s. Whether this finding is an artifact of investigators' inability to recruit participants with more pain or an indication of improvements in cancer pain management requires additional study. Given the extensive focus on educating health professionals about cancer pain management, the finding may be an outcome of the World Health Organization's (1996) efforts and those of other professional organizations (Mercadante, 2007) .
Strengths and Weaknesses of the MPQ for Cancer Pain
There are four strengths of the MPQ. First, the MPQ is a measure of the multiple components (sensory, affective, cognitive, behavioral) of cancer pain (Ahles et al., 1983; Melzack, 1975) , including the nociceptive and neuropathic components of the sensory pain dimension (Wilkie et al., 2001) . Second, it allows investigators to collect both quantitative and qualitative data for analysis. Third, the MPQ has good construct, content, and criterion validity (Ahles et al., 1983; Fischer et al., 2009; Heim & Oei, 1993; Kremer et al., 1982; Melzack, 1975; Sist et al., 1998; Wilkie et al., 2001; Wilkie & Keefe, 1991; Wilkie et al., 1992; Zimmerman et al., 1996) , strong reliability for measuring cancer pain (Graham et al., 1980; Wilkie & Keefe, 1991) , sensitivity to treatment effect (Epstein & Stewart, 1993; Epstein et al., 2009; Huang, Wilkie, Chapman et al., 2003; Macdonald et al., 2005; Peintinger et al., 2003; Samuelsson & Hedner, 1991; Talmi et al., 1997) , and sensitivity to intervention effect (Beck, 1991; Zimmerman et al., 1989) . And fourth, the MPQ can be used in many cultures and languages to which it has been translated (Menezes Costa Lda et al., 2009) .
However, the MPQ also has three weaknesses. First, the MPQ takes a long time to complete, especially compared with measures of only one part of the sensory dimension, such as the pain intensity. Second, there are concerns about readability issues for some descriptors. And third, three pain patterns of the MPQ are not adequate to account for changes in pain experienced by cancer participants (Graham et al., 1980) .
Limitations
The present review provides a broad review of the use of the MPQ as a multidimensional tool to measure cancer pain. This systematic review is limited by focusing on adults (>15 years old) living with cancer, not pediatric participants, because pain measurement by the MPQ requires knowledge of the language to describe pain. Another limitation is that the search strategy may not have identified all relevant studies.
Suggestions and Further Studies
Further studies are needed to improve the MPQ. First, studies should be conducted with improvements in research methods and inclusion of a large number of participants living with cancer pain so that the results can be more generalizable. Second, measuring cancer pain in a sample of participants with various stages of disease and from different sociocultural backgrounds would help to ascertain if the MPQ can be used appropriately for those purposes. Third, additional longitudinal studies are needed to characterize cancer pain over the disease trajectory. Fourth, the use of sensory pain, especially pattern and location and the affective, cognitive, and behavior pain requires more study to confirm that the MPQ is an appropriate measure for these aspects of cancer pain. Finally, additional research is needed regarding quantification of the aggravating and alleviating behaviors/factors to expand knowledge about their relationships with other sensory pain parameters and disease progression.
Nursing Implications
There are several important points that investigators and clinicians need to consider as they select pain measurement tools. First, clinicians must know the purposes for measuring the pain dimensions so that they can select valid and reliable tools that are most suitable for the clinical settings and participants' physical and mental conditions. Second, one needs to know when pain should be measured; participants who took pain medications may affect their pain reports. Third, it should be kept in mind that there are different patient characteristics, including age, nonmalignant or malignant disease, nociceptive or neuropathic pain, and physical or cognitive impairments, all of which may affect the participant's pain and pain description. Finally, although participants took more time to complete the long form of the MPQ, that may not be appropriate for all clinics, and the MPQ is also available as a short form (Melzack, 1987) and a computerized software program (Huang, Wilkie, Zong et al., 2003; Wilkie et al., 2003) that is easy to use and takes less time. Therefore, these latter methods can be considered in clinical practice for better documentation of pain and to guide pain treatments.
CONCLUSIONS
This integrative review provided a broad review of the MPQ as a multidimensional tool. Thirty studies were identified and evaluated to support that the MPQ is a valid and reliable measure of the sensory, affective, cognitive, and behavioral dimensions of cancer pain. All four dimensions were related to each other, but not so strongly as to be redundant. In spite of cancer pain being a complex phenomenon, it is very difficult to measure and manage cancer pain. Further extensive research is needed on measuring simultaneously the multiple dimensions of cancer pain and doing so longitudinally over the cancer trajectory. No single instrument is a gold standard pain tool for clinical pain research and practice; however, the combination of the MPQ and other instruments can be an efficient method for clinically assessing cancer pain as a patient-reported outcome (PRO) and for obtaining adequate data in clinical research. a draft version of this manuscript when she worked at Department of Biobehavioral Health Science College of Nursing, University of Illinois, Chicago. The authors also thank Kevin Grandfield for editorial assistance.
